{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T17:04:33Z","timestamp":1783184673134,"version":"3.54.6"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00277-022-04760-8","type":"journal-article","created":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T08:02:50Z","timestamp":1642233770000},"page":"799-810","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prognostic implication of CTLA-4, PD-1, and PD-L1 expression in aggressive adult T-cell leukemia\u2013lymphoma"],"prefix":"10.1007","volume":"101","author":[{"given":"Akio","family":"Onishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5118-7950","authenticated-orcid":false,"given":"Shigeo","family":"Fuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigehisa","family":"Kitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko Miyagi","family":"Maeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinuko","family":"Tajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihisa","family":"Kawajiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonari","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumu","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Okinaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Inamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiko","family":"Kurosawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Munakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensei","family":"Tobinai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,15]]},"reference":[{"issue":"11","key":"4760_CR1","doi-asserted-by":"publisher","first-page":"e517","DOI":"10.1016\/s1470-2045(14)70202-5","volume":"15","author":"K Ishitsuka","year":"2014","unstructured":"Ishitsuka K, Tamura K (2014) Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. Lancet Oncol 15(11):e517-526. https:\/\/doi.org\/10.1016\/s1470-2045(14)70202-5","journal-title":"Lancet Oncol"},{"issue":"3","key":"4760_CR2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","volume":"79","author":"M Shimoyama","year":"1991","unstructured":"Shimoyama M (1991) Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984\u201387). Br J Haematol 79(3):428\u2013437. https:\/\/doi.org\/10.1111\/j.1365-2141.1991.tb08051.x","journal-title":"Br J Haematol"},{"issue":"12","key":"4760_CR3","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1111\/cas.14658","volume":"111","author":"Y Imaizumi","year":"2020","unstructured":"Imaizumi Y, Iwanaga M, Nosaka K, Ishitsuka K, Ishizawa K, Ito S, Amano M, Ishida T, Uike N, Utsunomiya A, Ohshima K, Tanaka J, Tokura Y, Tobinai K, Watanabe T, Uchimaru K, Tsukasaki K (2020) Prognosis of patients with adult T-cell leukemia\/lymphoma in Japan: a nationwide hospital-based study. Cancer Sci 111(12):4567\u20134580. https:\/\/doi.org\/10.1111\/cas.14658","journal-title":"Cancer Sci"},{"issue":"3","key":"4760_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1200\/jco.2008.18.2428","volume":"27","author":"K Tsukasaki","year":"2009","unstructured":"Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington W Jr, O\u2019Mahony D, Janik JE, Bittencourt AL, Taylor GP, Yamaguchi K, Utsunomiya A, Tobinai K, Watanabe T (2009) Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol 27(3):453\u2013459. https:\/\/doi.org\/10.1200\/jco.2008.18.2428","journal-title":"J Clin Oncol"},{"issue":"14","key":"4760_CR5","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1200\/jco.2011.38.2101","volume":"30","author":"H Katsuya","year":"2012","unstructured":"Katsuya H, Yamanaka T, Ishitsuka K, Utsunomiya A, Sasaki H, Hanada S, Eto T, Moriuchi Y, Saburi Y, Miyahara M, Sueoka E, Uike N, Yoshida S, Yamashita K, Tsukasaki K, Suzushima H, Ohno Y, Matsuoka H, Jo T, Suzumiya J, Tamura K (2012) Prognostic index for acute- and lymphoma-type adult T-cell leukemia\/lymphoma. J Clin Oncol 30(14):1635\u20131640. https:\/\/doi.org\/10.1200\/jco.2011.38.2101","journal-title":"J Clin Oncol"},{"issue":"34","key":"4760_CR6","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.1200\/jco.2007.11.9958","volume":"25","author":"K Tsukasaki","year":"2007","unstructured":"Tsukasaki K, Utsunomiya A, Fukuda H, Shibata T, Fukushima T, Takatsuka Y, Ikeda S, Masuda M, Nagoshi H, Ueda R, Tamura K, Sano M, Momita S, Yamaguchi K, Kawano F, Hanada S, Tobinai K, Shimoyama M, Hotta T, Tomonaga M (2007) VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol 25(34):5458\u20135464. https:\/\/doi.org\/10.1200\/jco.2007.11.9958","journal-title":"J Clin Oncol"},{"issue":"5","key":"4760_CR7","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/bjh.12962","volume":"166","author":"T Fukushima","year":"2014","unstructured":"Fukushima T, Nomura S, Shimoyama M, Shibata T, Imaizumi Y, Moriuchi Y, Tomoyose T, Uozumi K, Kobayashi Y, Fukushima N, Utsunomiya A, Tara M, Nosaka K, Hidaka M, Uike N, Yoshida S, Tamura K, Ishitsuka K, Kurosawa M, Nakata M, Fukuda H, Hotta T, Tobinai K, Tsukasaki K (2014) Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A). Br J Haematol 166(5):739\u2013748. https:\/\/doi.org\/10.1111\/bjh.12962","journal-title":"Br J Haematol"},{"issue":"8","key":"4760_CR8","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1200\/JCO.18.00501","volume":"37","author":"LB Cook","year":"2019","unstructured":"Cook LB, Fuji S, Hermine O, Bazarbachi A, Ramos JC, Ratner L, Horwitz S, Fields P, Tanase A, Bumbea H, Cwynarski K, Taylor G, Waldmann TA, Bittencourt A, Marcais A, Suarez F, Sibon D, Phillips A, Lunning M, Farid R, Imaizumi Y, Choi I, Ishida T, Ishitsuka K, Fukushima T, Uchimaru K, Takaori-Kondo A, Tokura Y, Utsunomiya A, Matsuoka M, Tsukasaki K, Watanabe T (2019) Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report. J Clin Oncol 37(8):677\u2013687. https:\/\/doi.org\/10.1200\/JCO.18.00501","journal-title":"J Clin Oncol"},{"issue":"6","key":"4760_CR9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1182\/bloodadvances.2017011106","volume":"2","author":"L Malpica","year":"2018","unstructured":"Malpica L, Pimentel A, Reis IM, Gotuzzo E, Lekakis L, Komanduri K, Harrington T, Barber GN, Ramos JC (2018) Epidemiology, clinical features, and outcome of HTLV-1-related ATLL in an area of prevalence in the United States. Blood Adv 2(6):607\u2013620. https:\/\/doi.org\/10.1182\/bloodadvances.2017011106","journal-title":"Blood Adv"},{"issue":"8","key":"4760_CR10","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1182\/blood-2009-10-247510","volume":"116","author":"M Hishizawa","year":"2010","unstructured":"Hishizawa M, Kanda J, Utsunomiya A, Taniguchi S, Eto T, Moriuchi Y, Tanosaki R, Kawano F, Miyazaki Y, Masuda M, Nagafuji K, Hara M, Takanashi M, Kai S, Atsuta Y, Suzuki R, Kawase T, Matsuo K, Nagamura-Inoue T, Kato S, Sakamaki H, Morishima Y, Okamura J, Ichinohe T, Uchiyama T (2010) Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Blood 116(8):1369\u20131376. https:\/\/doi.org\/10.1182\/blood-2009-10-247510","journal-title":"Blood"},{"issue":"8","key":"4760_CR11","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1182\/blood-2012-03-414490","volume":"120","author":"T Ishida","year":"2012","unstructured":"Ishida T, Hishizawa M, Kato K, Tanosaki R, Fukuda T, Taniguchi S, Eto T, Takatsuka Y, Miyazaki Y, Moriuchi Y, Hidaka M, Akashi K, Uike N, Sakamaki H, Morishima Y, Kato K, Suzuki R, Nishiyama T, Utsunomiya A (2012) Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study. Blood 120(8):1734\u20131741. https:\/\/doi.org\/10.1182\/blood-2012-03-414490","journal-title":"Blood"},{"issue":"9","key":"4760_CR12","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1182\/blood-2011-07-368233","volume":"119","author":"J Kanda","year":"2012","unstructured":"Kanda J, Hishizawa M, Utsunomiya A, Taniguchi S, Eto T, Moriuchi Y, Tanosaki R, Kawano F, Miyazaki Y, Masuda M, Nagafuji K, Hara M, Takanashi M, Kai S, Atsuta Y, Suzuki R, Kawase T, Matsuo K, Nagamura-Inoue T, Kato S, Sakamaki H, Morishima Y, Okamura J, Ichinohe T, Uchiyama T (2012) Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study. Blood 119(9):2141\u20132148. https:\/\/doi.org\/10.1182\/blood-2011-07-368233","journal-title":"Blood"},{"issue":"3","key":"4760_CR13","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/bmt.2016.313","volume":"52","author":"H Fujiwara","year":"2017","unstructured":"Fujiwara H, Fuji S, Wake A, Kato K, Takatsuka Y, Fukuda T, Taguchi J, Uchida N, Miyamoto T, Hidaka M, Miyazaki Y, Tomoyose T, Onizuka M, Takanashi M, Ichinohe T, Atsuta Y, Utsunomiya A, Transplantation ATLWGotJSfHC, (2017) Dismal outcome of allogeneic hematopoietic stem cell transplantation for relapsed adult T-cell leukemia\/lymphoma, a Japanese nation-wide study. Bone Marrow Transplant 52(3):484\u2013488. https:\/\/doi.org\/10.1038\/bmt.2016.313","journal-title":"Bone Marrow Transplant"},{"issue":"28","key":"4760_CR14","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1200\/jco.2016.67.8250","volume":"34","author":"S Fuji","year":"2016","unstructured":"Fuji S, Inoue Y, Utsunomiya A, Moriuchi Y, Uchimaru K, Choi I, Otsuka E, Henzan H, Kato K, Tomoyose T, Yamamoto H, Kurosawa S, Matsuoka K, Yamaguchi T, Fukuda T (2016) Pretransplantation anti-CCR4 antibody mogamulizumab against adult t-cell leukemia\/lymphoma is associated with significantly increased risks of severe and corticosteroid-refractory graft-versus-host disease, nonrelapse mortality, and overall mortality. J Clin Oncol 34(28):3426\u20133433. https:\/\/doi.org\/10.1200\/jco.2016.67.8250","journal-title":"J Clin Oncol"},{"issue":"1","key":"4760_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3233\/dma-2010-0725","volume":"29","author":"S Muenst","year":"2010","unstructured":"Muenst S, Hoeller S, Willi N, Dirnhofera S, Tzankov A (2010) Diagnostic and prognostic utility of PD-1 in B cell lymphomas. Dis Markers 29(1):47\u201353. https:\/\/doi.org\/10.3233\/dma-2010-0725","journal-title":"Dis Markers"},{"issue":"12","key":"4760_CR16","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1001\/archdermatol.2012.2089","volume":"148","author":"F Cetinozman","year":"2012","unstructured":"Cetinozman F, Jansen PM, Vermeer MH, Willemze R (2012) Differential expression of programmed death-1 (PD-1) in Sezary syndrome and mycosis fungoides. Arch Dermatol 148(12):1379\u20131385. https:\/\/doi.org\/10.1001\/archdermatol.2012.2089","journal-title":"Arch Dermatol"},{"issue":"1","key":"4760_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/PAS.0b013e318230df87","volume":"36","author":"F Cetinozman","year":"2012","unstructured":"Cetinozman F, Jansen PM, Willemze R (2012) Expression of programmed death-1 in primary cutaneous CD4-positive small\/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma. Am J Surg Pathol 36(1):109\u2013116. https:\/\/doi.org\/10.1097\/PAS.0b013e318230df87","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"4760_CR18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.humpath.2010.08.015","volume":"42","author":"BG Richendollar","year":"2011","unstructured":"Richendollar BG, Pohlman B, Elson P, Hsi ED (2011) Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma. Hum Pathol 42(4):552\u2013557. https:\/\/doi.org\/10.1016\/j.humpath.2010.08.015","journal-title":"Hum Pathol"},{"issue":"27","key":"4760_CR19","doi-asserted-by":"publisher","first-page":"44960","DOI":"10.18632\/oncotarget.16680","volume":"8","author":"P Gravelle","year":"2017","unstructured":"Gravelle P, Burroni B, Pericart S, Rossi C, Bezombes C, Tosolini M, Damotte D, Brousset P, Fournie JJ, Laurent C (2017) Mechanisms of PD-1\/PD-L1 expression and prognostic relevance in non-Hodgkin lymphoma: a summary of immunohistochemical studies. Oncotarget 8(27):44960\u201344975. https:\/\/doi.org\/10.18632\/oncotarget.16680","journal-title":"Oncotarget"},{"issue":"11","key":"4760_CR20","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1158\/1078-0432.ccr-13-2367","volume":"20","author":"JP Smeltzer","year":"2014","unstructured":"Smeltzer JP, Jones JM, Ziesmer SC, Grote DM, Xiu B, Ristow KM, Yang ZZ, Nowakowski GS, Feldman AL, Cerhan JR, Novak AJ, Ansell SM (2014) Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphoma. Clin Cancer Res 20(11):2862\u20132872. https:\/\/doi.org\/10.1158\/1078-0432.ccr-13-2367","journal-title":"Clin Cancer Res"},{"key":"4760_CR21","doi-asserted-by":"publisher","first-page":"e281","DOI":"10.1038\/bcj.2015.1","volume":"5","author":"ZZ Yang","year":"2015","unstructured":"Yang ZZ, Grote DM, Ziesmer SC, Xiu B, Novak AJ, Ansell SM (2015) PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival. Blood Cancer J 5:e281. https:\/\/doi.org\/10.1038\/bcj.2015.1","journal-title":"Blood Cancer J"},{"issue":"11","key":"4760_CR22","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1002\/cam4.874","volume":"5","author":"W Zhang","year":"2016","unstructured":"Zhang W, Bai JF, Zuo MX, Cao XX, Chen M, Zhang Y, Han X, Zhong DR, Zhou DB (2016) PD-1 expression on the surface of peripheral blood CD4+ T cell and its association with the prognosis of patients with diffuse large B-cell lymphoma. Cancer Med 5(11):3077\u20133084. https:\/\/doi.org\/10.1002\/cam4.874","journal-title":"Cancer Med"},{"issue":"7","key":"4760_CR23","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/01.pas.0000209855.28282.ce","volume":"30","author":"DM Dorfman","year":"2006","unstructured":"Dorfman DM, Brown JA, Shahsafaei A, Freeman GJ (2006) Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 30(7):802\u2013810. https:\/\/doi.org\/10.1097\/01.pas.0000209855.28282.ce","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"4760_CR24","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.humpath.2007.11.012","volume":"39","author":"L Xerri","year":"2008","unstructured":"Xerri L, Chetaille B, Serriari N, Attias C, Guillaume Y, Arnoulet C, Olive D (2008) Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma\/chronic lymphocytic leukemia. Hum Pathol 39(7):1050\u20131058. https:\/\/doi.org\/10.1016\/j.humpath.2007.11.012","journal-title":"Hum Pathol"},{"issue":"8","key":"4760_CR25","doi-asserted-by":"publisher","first-page":"e1026530","DOI":"10.1080\/2162402x.2015.1026530","volume":"4","author":"C Laurent","year":"2015","unstructured":"Laurent C, Charmpi K, Gravelle P, Tosolini M, Franchet C, Ysebaert L, Brousset P, Bidaut A, Ycart B, Fournie JJ (2015) Several immune escape patterns in non-Hodgkin\u2019s lymphomas. Oncoimmunology 4(8):e1026530. https:\/\/doi.org\/10.1080\/2162402x.2015.1026530","journal-title":"Oncoimmunology"},{"issue":"2","key":"4760_CR26","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1158\/1078-0432.ccr-09-2487","volume":"16","author":"BE Wahlin","year":"2010","unstructured":"Wahlin BE, Aggarwal M, Montes-Moreno S, Gonzalez LF, Roncador G, Sanchez-Verde L, Christensson B, Sander B, Kimby E (2010) A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1\u2013positive, regulatory, cytotoxic, and helper T cells and macrophages. Clin Cancer Res 16(2):637\u2013650. https:\/\/doi.org\/10.1158\/1078-0432.ccr-09-2487","journal-title":"Clin Cancer Res"},{"issue":"10","key":"4760_CR27","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1182\/blood-2009-04-216671","volume":"114","author":"RA Wilcox","year":"2009","unstructured":"Wilcox RA, Feldman AL, Wada DA, Yang ZZ, Comfere NI, Dong H, Kwon ED, Novak AJ, Markovic SN, Pittelkow MR, Witzig TE, Ansell SM (2009) B7\u2013H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders. Blood 114(10):2149\u20132158. https:\/\/doi.org\/10.1182\/blood-2009-04-216671","journal-title":"Blood"},{"issue":"7","key":"4760_CR28","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/his.12882","volume":"68","author":"D Kwon","year":"2016","unstructured":"Kwon D, Kim S, Kim PJ, Go H, Nam SJ, Paik JH, Kim YA, Kim TM, Heo DS, Kim CW, Jeon YK (2016) Clinicopathological analysis of programmed cell death 1 and programmed cell death ligand 1 expression in the tumour microenvironments of diffuse large B cell lymphomas. Histopathology 68(7):1079\u20131089. https:\/\/doi.org\/10.1111\/his.12882","journal-title":"Histopathology"},{"key":"4760_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.humpath.2016.03.005","volume":"54","author":"T Menter","year":"2016","unstructured":"Menter T, Bodmer-Haecki A, Dirnhofer S, Tzankov A (2016) Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomas. Hum Pathol 54:17\u201324. https:\/\/doi.org\/10.1016\/j.humpath.2016.03.005","journal-title":"Hum Pathol"},{"issue":"19","key":"4760_CR30","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1182\/blood-2015-02-629600","volume":"126","author":"J Kiyasu","year":"2015","unstructured":"Kiyasu J, Miyoshi H, Hirata A, Arakawa F, Ichikawa A, Niino D, Sugita Y, Yufu Y, Choi I, Abe Y, Uike N, Nagafuji K, Okamura T, Akashi K, Takayanagi R, Shiratsuchi M, Ohshima K (2015) Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma. Blood 126(19):2193\u20132201. https:\/\/doi.org\/10.1182\/blood-2015-02-629600","journal-title":"Blood"},{"issue":"13","key":"4760_CR31","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1158\/1078-0432.ccr-13-0855","volume":"19","author":"BJ Chen","year":"2013","unstructured":"Chen BJ, Chapuy B, Ouyang J, Sun HH, Roemer MG, Xu ML, Yu H, Fletcher CD, Freeman GJ, Shipp MA, Rodig SJ (2013) PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies. Clin Cancer Res 19(13):3462\u20133473. https:\/\/doi.org\/10.1158\/1078-0432.ccr-13-0855","journal-title":"Clin Cancer Res"},{"issue":"10","key":"4760_CR32","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1182\/blood-2016-02-698936","volume":"128","author":"H Miyoshi","year":"2016","unstructured":"Miyoshi H, Kiyasu J, Kato T, Yoshida N, Shimono J, Yokoyama S, Taniguchi H, Sasaki Y, Kurita D, Kawamoto K, Kato K, Imaizumi Y, Seto M, Ohshima K (2016) PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia\/lymphoma. Blood 128(10):1374\u20131381. https:\/\/doi.org\/10.1182\/blood-2016-02-698936","journal-title":"Blood"},{"issue":"11","key":"4760_CR33","doi-asserted-by":"publisher","first-page":"e0166266","DOI":"10.1371\/journal.pone.0166266","volume":"11","author":"S Vranic","year":"2016","unstructured":"Vranic S, Ghosh N, Kimbrough J, Bilalovic N, Bender R, Arguello D, Veloso Y, Dizdarevic A, Gatalica Z (2016) PD-L1 status in refractory lymphomas. PLoS ONE 11(11):e0166266. https:\/\/doi.org\/10.1371\/journal.pone.0166266","journal-title":"PLoS ONE"},{"issue":"13","key":"4760_CR34","doi-asserted-by":"publisher","first-page":"4232","DOI":"10.1158\/1078-0432.ccr-10-2660","volume":"17","author":"DJ Andorsky","year":"2011","unstructured":"Andorsky DJ, Yamada RE, Said J, Pinkus GS, Betting DJ, Timmerman JM (2011) Programmed death ligand 1 is expressed by non-hodgkin lymphomas and inhibits the activity of tumor-associated T cells. Clin Cancer Res 17(13):4232\u20134244. https:\/\/doi.org\/10.1158\/1078-0432.ccr-10-2660","journal-title":"Clin Cancer Res"},{"issue":"30","key":"4760_CR35","doi-asserted-by":"publisher","first-page":"47252","DOI":"10.18632\/oncotarget.10055","volume":"7","author":"K Hatogai","year":"2016","unstructured":"Hatogai K, Kitano S, Fujii S, Kojima T, Daiko H, Nomura S, Yoshino T, Ohtsu A, Takiguchi Y, Doi T, Ochiai A (2016) Comprehensive immunohistochemical analysis of tumor microenvironment immune status in esophageal squamous cell carcinoma. Oncotarget 7(30):47252\u201347264. https:\/\/doi.org\/10.18632\/oncotarget.10055","journal-title":"Oncotarget"},{"issue":"7","key":"4760_CR36","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00262-015-1696-2","volume":"64","author":"H Yu","year":"2015","unstructured":"Yu H, Yang J, Jiao S, Li Y, Zhang W, Wang J (2015) Cytotoxic T lymphocyte antigen 4 expression in human breast cancer: implications for prognosis. Cancer Immunol Immunother 64(7):853\u2013860. https:\/\/doi.org\/10.1007\/s00262-015-1696-2","journal-title":"Cancer Immunol Immunother"},{"issue":"17","key":"4760_CR37","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","volume":"373","author":"H Borghaei","year":"2015","unstructured":"Borghaei H, Paz-Ares L, Horn L, Spigel DR, Steins M, Ready NE, Chow LQ, Vokes EE, Felip E, Holgado E, Barlesi F, Kohlhaufl M, Arrieta O, Burgio MA, Fayette J, Lena H, Poddubskaya E, Gerber DE, Gettinger SN, Rudin CM, Rizvi N, Crino L, Blumenschein GR Jr, Antonia SJ, Dorange C, Harbison CT, Graf Finckenstein F, Brahmer JR (2015) Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med 373(17):1627\u20131639. https:\/\/doi.org\/10.1056\/NEJMoa1507643","journal-title":"N Engl J Med"},{"issue":"2","key":"4760_CR38","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa1504627","volume":"373","author":"J Brahmer","year":"2015","unstructured":"Brahmer J, Reckamp KL, Baas P, Crino L, Eberhardt WE, Poddubskaya E, Antonia S, Pluzanski A, Vokes EE, Holgado E, Waterhouse D, Ready N, Gainor J, Aren Frontera O, Havel L, Steins M, Garassino MC, Aerts JG, Domine M, Paz-Ares L, Reck M, Baudelet C, Harbison CT, Lestini B, Spigel DR (2015) Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. N Engl J Med 373(2):123\u2013135. https:\/\/doi.org\/10.1056\/NEJMoa1504627","journal-title":"N Engl J Med"},{"issue":"10027","key":"4760_CR39","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/s0140-6736(15)01281-7","volume":"387","author":"RS Herbst","year":"2016","unstructured":"Herbst RS, Baas P, Kim DW, Felip E, Perez-Gracia JL, Han JY, Molina J, Kim JH, Arvis CD, Ahn MJ, Majem M, Fidler MJ, de Castro G, Jr., Garrido M, Lubiniecki GM, Shentu Y, Im E, Dolled-Filhart M, Garon EB, (2016) Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. Lancet 387(10027):1540\u20131550. https:\/\/doi.org\/10.1016\/s0140-6736(15)01281-7","journal-title":"Lancet"},{"issue":"9","key":"4760_CR40","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/s1470-2045(16)30167-x","volume":"17","author":"A Younes","year":"2016","unstructured":"Younes A, Santoro A, Shipp M, Zinzani PL, Timmerman JM, Ansell S, Armand P, Fanale M, Ratanatharathorn V, Kuruvilla J, Cohen JB, Collins G, Savage KJ, Trneny M, Kato K, Farsaci B, Parker SM, Rodig S, Roemer MG, Ligon AH, Engert A (2016) Nivolumab for classical Hodgkin\u2019s lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial. Lancet Oncol 17(9):1283\u20131294. https:\/\/doi.org\/10.1016\/s1470-2045(16)30167-x","journal-title":"Lancet Oncol"},{"issue":"5","key":"4760_CR41","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00277-020-03967-x","volume":"99","author":"M Takeuchi","year":"2020","unstructured":"Takeuchi M, Miyoshi H, Nakashima K, Kawamoto K, Yamada K, Yanagida E, Muta H, Moritsubo M, Umeno T, Suzuki T, Seto M, Ohshima K (2020) Comprehensive immunohistochemical analysis of immune checkpoint molecules in adult T cell leukemia\/lymphoma. Ann Hematol 99(5):1093\u20131098. https:\/\/doi.org\/10.1007\/s00277-020-03967-x","journal-title":"Ann Hematol"},{"issue":"3","key":"4760_CR42","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant 48(3):452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"4760_CR43","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1182\/blood-2012-02-411678","volume":"120","author":"AG Ramsay","year":"2012","unstructured":"Ramsay AG, Clear AJ, Fatah R, Gribben JG (2012) Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer. Blood 120(7):1412\u20131421. https:\/\/doi.org\/10.1182\/blood-2012-02-411678","journal-title":"Blood"},{"key":"4760_CR44","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3389\/fphar.2017.00561","volume":"8","author":"HO Alsaab","year":"2017","unstructured":"Alsaab HO, Sau S, Alzhrani R, Tatiparti K, Bhise K, Kashaw SK, Iyer AK (2017) PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome. Front Pharmacol 8:561. https:\/\/doi.org\/10.3389\/fphar.2017.00561","journal-title":"Front Pharmacol"},{"key":"4760_CR45","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-01-761874","author":"K Kataoka","year":"2017","unstructured":"Kataoka K, Iwanaga M, Yasunaga JI, Nagata Y, Kitanaka A, Kameda T, Yoshimitsu M, Shiraishi Y, Sato-Otsubo A, Sanada M, Chiba K, Tanaka H, Ochi Y, Aoki K, Suzuki H, Shiozawa Y, Yoshizato T, Sato Y, Yoshida K, Nosaka K, Hishizawa M, Itonaga H, Imaizumi Y, Munakata W, Shide K, Kubuki Y, Hidaka T, Nakamaki T, Ishiyama K, Miyawaki S, Ishii R, Nureki O, Tobinai K, Miyazaki Y, Takaori-Kondo A, Shibata T, Miyano S, Ishitsuka K, Utsunomiya A, Shimoda K, Matsuoka M, Watanabe T, Ogawa S (2017) Prognostic relevance of integrated genetic profiling in adult T-cell leukemia\/lymphoma. Blood. https:\/\/doi.org\/10.1182\/blood-2017-01-761874","journal-title":"Blood"},{"issue":"20","key":"4760_CR46","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1056\/NEJMc1803181","volume":"378","author":"L Ratner","year":"2018","unstructured":"Ratner L, Waldmann TA, Janakiram M, Brammer JE (2018) Rapid Progression of Adult T-Cell Leukemia-Lymphoma after PD-1 Inhibitor Therapy. N Engl J Med 378(20):1947\u20131948. https:\/\/doi.org\/10.1056\/NEJMc1803181","journal-title":"N Engl J Med"},{"issue":"17","key":"4760_CR47","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1182\/blood.2019002038","volume":"134","author":"DA Rauch","year":"2019","unstructured":"Rauch DA, Conlon KC, Janakiram M, Brammer JE, Harding JC, Ye BH, Zang X, Ren X, Olson S, Cheng X, Miljkovic MD, Sundaramoorthi H, Joseph A, Skidmore ZL, Griffith O, Griffith M, Waldmann TA, Ratner L (2019) Rapid progression of adult T-cell leukemia\/lymphoma as tumor-infiltrating Tregs after PD-1 blockade. Blood 134(17):1406\u20131414. https:\/\/doi.org\/10.1182\/blood.2019002038","journal-title":"Blood"},{"issue":"1","key":"4760_CR48","doi-asserted-by":"publisher","first-page":"e1005372","DOI":"10.1371\/journal.ppat.1005372","volume":"12","author":"K Yasuma","year":"2016","unstructured":"Yasuma K, Yasunaga J, Takemoto K, Sugata K, Mitobe Y, Takenouchi N, Nakagawa M, Suzuki Y, Matsuoka M (2016) HTLV-1 bZIP factor impairs anti-viral immunity by inducing co-inhibitory molecule, T cell immunoglobulin and ITIM domain (TIGIT). PLoS Pathog 12(1):e1005372. https:\/\/doi.org\/10.1371\/journal.ppat.1005372","journal-title":"PLoS Pathog"},{"key":"4760_CR49","doi-asserted-by":"crossref","unstructured":"Querfeld C, Wu X, Stiller T, et al (2019) Phase 1 Results of Anti-PD-Ligand 1 (Durvalumab) & Lenalidomide in Patients with Cutaneous T Cell Lymphoma and Correlation with Programmed Death Ligand 1 Expression and Gene Expression Profile[abstract]. 61th ASH Annual Meeting. Abstract 4024","DOI":"10.1182\/blood-2019-126358"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04760-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-022-04760-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04760-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T12:06:56Z","timestamp":1646914016000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-022-04760-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,15]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["4760"],"URL":"https:\/\/doi.org\/10.1007\/s00277-022-04760-8","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,15]]},"assertion":[{"value":"23 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}